1.6900
0.0000
(0.00%)
At close: 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 181k | -- |
| Sales Growth (year/est) | -- | -- | -100.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.06 | -0.05 | -0.08 |
| EPS Actual | -0.05 | -0.06 | -0.08 | -0.06 |
| Difference | 0.01 | 0 | -0.03 | 0.02 |
| Surprise % | 16.67% | 0.00% | -60.00% | 25.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ENTX | -- | -- | -- | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/27/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/5/2024 |
Related Tickers
XTLB XTL Biopharmaceuticals Ltd.
1.1250
-3.85%
PLUR Pluri Inc.
3.8150
+2.01%
NERV Minerva Neurosciences, Inc.
1.4500
+6.23%
EPRX Eupraxia Pharmaceuticals Inc.
3.0250
-0.17%
THRD Third Harmonic Bio, Inc.
3.6400
+4.90%
APRE Aprea Therapeutics, Inc.
1.5500
0.00%
SYBX Synlogic, Inc.
1.0250
-2.38%
CGEN Compugen Ltd.
1.2600
+4.13%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
PYPD PolyPid Ltd.
2.4800
-0.60%